Sigma-Aldrich Posts 5 Percent Revenue Growth for Q3 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported 5 percent revenue growth on the strength of its fine chemicals business. Excluding the effect of foreign currency exchange rates, its revenues were up 7 percent.

The St. Louis-based research products and chemicals firm brought in total revenues of $563 million for the three-month period ended Sept. 30, compared with $534 million for Q3 2009. Analysts, on average, had expected sales of $542.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.